NM_001005242.3:c.259G>C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2
The NM_001005242.3(PKP2):c.259G>C(p.Val87Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000112 in 1,604,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. V87V) has been classified as Likely benign.
Frequency
Consequence
NM_001005242.3 missense
Scores
Clinical Significance
Conservation
Publications
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- arrhythmogenic right ventricular dysplasia 9Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- left ventricular noncompactionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Brugada syndromeInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- dilated cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152148Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251410 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000964 AC: 14AN: 1452656Hom.: 0 Cov.: 29 AF XY: 0.0000111 AC XY: 8AN XY: 723222 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74332 show subpopulations
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 9 Uncertain:2
This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 87 of the PKP2 protein (p.Val87Leu). This variant is present in population databases (rs750028032, gnomAD 0.002%). This missense change has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy (PMID: 20400443). ClinVar contains an entry for this variant (Variation ID: 464428). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
This missense variant replaces valine with leucine at codon 87 of the PKP2 protein. Computational prediction suggests that this variant may not impact protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic cardiomyopathy (PMID: 20400443, 30790397, 33652588) and in an individual affected with hypertrophic cardiomyopathy (PMID: 25351510). This variant has been observed in three individuals affected with arrhythmogenic cardiomyopathy in the compound heterozygous state with another pathogenic truncating variant in the same gene that could explain the observed phenotype (PMID: 20400443, 30790397). This variant has been identified in 4/282806 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
This missense variant replaces valine with leucine at codon 87 of the PKP2 protein. Computational prediction suggests that this variant may not impact protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic cardiomyopathy (PMID: 20400443, 30790397, 33652588) and in an individual affected with hypertrophic cardiomyopathy (PMID: 25351510). This variant has been observed in three individuals affected with arrhythmogenic cardiomyopathy in the compound heterozygous state with another pathogenic truncating variant in the same gene that could explain the observed phenotype (PMID: 20400443, 30790397). This variant has been identified in 4/282806 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.V87L variant (also known as c.259G>C), located in coding exon 2 of the PKP2 gene, results from a G to C substitution at nucleotide position 259. The valine at codon 87 is replaced by leucine, an amino acid with highly similar properties. This alteration has been reported in arrhythmogenic right ventricular cardiomyopathy (ARVC) cohorts; however, clinical details were limited and an additional alteration in PKP2 was identified in a case (Fressart V et al. Europace, 2010 Jun;12:861-8; Mates J et al. Eur J Hum Genet, 2018 Jul;26:1014-1025; Hermida A et al. Eur J Heart Fail, 2019 Jun;21:792-800; Vallverdú-Prats M et al. J Pers Med, 2021 Feb;11:[ePub ahead of print]). Additionally, this alteration has been reported in a hypertrophic cardiomyopathy (HCM) cohort; however, clinical details were limited (Lopes LR et al. Heart, 2015 Feb;101:294-301). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at